Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
1996-07-02
Seidleck, James J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544146, 546202, 548523, 548525, 549 44, 549 52, 549 53, 549 54, 562843, 562868, A01N 4340
Patent
active
055322549
ABSTRACT:
A method for modulating calcium channels, increasing the density of calcium channels in vascular and cardiac tissue with no changes in inotropic or pressor response, comprising administering to a warm-blooded animal in need thereof a pharmaceutically-effective amount of a compound having the formula ##STR1## wherein R.sup.1 and R.sup.3 are independently hydrogen, C.sub.1 -C.sub.4 alkyl, --CO--(C.sub.1 -C.sub.6 alkyl), or --CH.sub.2 Ar, --CO--Ar, wherein Ar is phenyl or substituted phenyl;
REFERENCES:
patent: 4133814 (1979-01-01), Jones et al.
patent: 4380635 (1983-04-01), Peters
patent: 4418068 (1983-11-01), Jones
Collins et al., "Cardiovascular Protection by Oestrogen--A Calcium Antagonist Effect?", Lancet, 341, 1264-65 (1993).
Jiang et al., "Endothelium-Independent Relaxation of Rabbit Coronary Artery by 17.beta.-Oestradiol In Vitro", Br. J. Pharmacol., 104, 1033-37 (1991).
Stice et al., "Interaction of 4-Hydroxylated Estradiol and Potential-Sensitive Ca.sup.2+ Channels in Altering Uterine Blood Flow during the Estrous Cycle and Early Pregnancy in Gilts", Biology of Reproduction, 36, 369-75 (1987).
Batra, "Influence of Chronic Oestrogen Treatment on the Density of Muscarinic Cholinergic Receptors and Calcium Channels in the Rabbit Uterus", J. Endocrin., 125, 185-188 (1990).
Wren, "The Effect of Oestrogen on the Female Cardiovascular System", Med. J. of Australia, 157, 204-208, (1992).
Zhang et al., "Sexual Dimorphism of Vascular Smooth Muscle Responsiveness is Dependent on Anions and Estrogen", Steroids, 56, 524-526 (1991).
Kanis, American Journal of Medicine "Treatment of Osteoporosis in Elderly Women". (1995) pp. 60-66.
Boone David E.
Eli Lilly and Company
Leeds James P.
Mosley Terressa
Seidleck James J.
LandOfFree
Modulation of calcium channels using benzothiophenes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulation of calcium channels using benzothiophenes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of calcium channels using benzothiophenes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1506687